Management of Diabetic Foot Ulcers with Sucrose-Octosulfate Hydrogel Formulations
Patient Selection and Treatment
- The International Working Group of the Diabetic Foot (IWGDF) provides a conditional recommendation with moderate certainty of evidence for using sucrose-octosulfate impregnated dressings in non-infected, neuro-ischemic diabetic foot ulcers that have failed to show adequate healing after at least 2 weeks of best standard care 1, 2, 3, 4, 5
- The American Diabetes Association recommends considering sucrose-octosulfate dressings for diabetic foot ulcers with a size greater than 1 cm² and a grade of IC or IIC (University of Texas classification) 1, 2, 4
- The IWGDF guidelines recommend against using sucrose-octosulfate dressings in patients with active infection of the wound 1, 2, 4
Treatment Outcomes
- Sucrose-octosulfate dressings have been shown to significantly improve complete wound healing at week 20, with a 48% healing rate compared to 30% in the control group (adjusted odds ratio 2.60, 95% CI 1.43-4.73; p=0.002) 1, 4
- The use of sucrose-octosulfate dressings has been associated with a faster estimated time to heal compared to placebo dressing 1, 4
- Sucrose-octosulfate dressings have been shown to increase percentage area reduction compared to control 1, 5
Safety and Cost-Effectiveness
- The IWGDF guidelines report a favorable safety profile for sucrose-octosulfate dressings, with few reported harms 1, 5
- Cost-effectiveness modeling studies from various Western healthcare systems are supportive of the use of sucrose-octosulfate dressings, with resource use considered low to moderate 1, 2, 5